Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?

Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?

BACKGROUND: Neuro- and vasoprotective effects of poly(ADP-ribose)polymerase (PARP) inhibition have been largely documented in models of cerebral ischemia, particularly with the potent PARP inhibitor PJ34. Furthermore, after ischemic stroke, physicians are faced with incomplete tissue reperfusion and...

Full description

Bibliographic Details
Main Authors:	Marie Lechaftois, Elise Dreano, Bruno Palmier, Isabelle Margaill, Catherine Marchand-Leroux, Christilla Bachelot-Loza, Dominique Lerouet
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4203827?pdf=render

Similar Items

Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases
by: Georges Jourdi, et al.
Published: (2021-12-01)

Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Reduces Brain Damage after Stroke in the Neonatal Mouse Brain
by: Philippe Bonnin, et al.
Published: (2021-06-01)

Neurological and histological consequences induced by in vivo cerebral oxidative stress: evidence for beneficial effects of SRT1720, a sirtuin 1 activator, and sirtuin 1-mediated neuroprotective effects of poly(ADP-ribose) polymerase inhibition.
by: Cindy Gueguen, et al.
Published: (2014-01-01)

Methods for Purification of Proteins Associated with Cellular Poly(ADP-Ribose) and PARP-Specific Poly(ADP-Ribose)
by: Rood, Jennifer E., et al.
Published: (2014)

In Vivo Level of Poly(ADP-ribose)
by: Masanao Miwa, et al.
Published: (2018-05-01)

Cerebral Vasodilator Property of Poly(ADP-Ribose) Polymerase Inhibitor (PJ34) in the Neonatal and Adult Mouse Is Mediated by the Nitric Oxide Pathway
by: Philippe Bonnin, et al.
Published: (2020-09-01)

The Antiviral Activities of Poly-ADP-Ribose Polymerases
by: Mathilde Malgras, et al.
Published: (2021-03-01)

ARH Family of ADP-Ribose-Acceptor Hydrolases
by: Hiroko Ishiwata-Endo, et al.
Published: (2022-11-01)

Adp-ribosyl cyclase and cyclic ADP-ribose hydrolase act as a redox sensor. a primary role for cyclic ADP-ribose in hypoxic pulmonary vasoconstriction.
by: Wilson, H, et al.
Published: (2001)

Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents
by: Emad Matanes, et al.
Published: (2021-10-01)

Another String to Our Bow: Participant Writing as Research Method
by: Vivienne Elizabeth
Published: (2008-01-01)

Selective monitoring of the protein-free ADP-ribose released by ADP-ribosylation reversal enzymes.
by: Samuel Kasson, et al.
Published: (2021-01-01)

Engineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins
by: Kathrin Nowak, et al.
Published: (2020-10-01)

Synthesis and use of cell-permeant cyclic ADP-ribose.
by: Rosen, D, et al.
Published: (2012)

Vasodilation by the calcium-mobilizing messenger cyclic ADP-ribose.
by: Boittin, F, et al.
Published: (2003)

Cyclic ADP ribose as a calcium-mobilizing messenger.
by: Galione, A, et al.
Published: (2000)

Pharmacological characterization of the putative cADP-ribose receptor.
by: Thomas, J, et al.
Published: (2001)

Genetically Encoded Fluorescent Sensor for Poly-ADP-Ribose
by: Ekaterina O. Serebrovskaya, et al.
Published: (2020-07-01)

Changes in NAD/ADP-ribose metabolism in rectal cancer
by: L. Yalcintepe, et al.
Published: (2005-03-01)

Molecular Insights into Poly(ADP-ribose) Recognition and Processing
by: Ivan Ahel, et al.
Published: (2012-12-01)

Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
by: Daniel Harrision, et al.
Published: (2020-08-01)

Fine-tuning of Smad protein function by poly(ADP-ribose) polymerases and poly(ADP-ribose) glycohydrolase during transforming growth factor β signaling.
by: Markus Dahl, et al.
Published: (2014-01-01)

Cancer‐associated fibroblasts: activin A adds another string to their bow
by: Remi Samain, et al.
Published: (2020-04-01)

Neuronal accumulation of poly(ADP-ribose) after brain ischaemia.
by: Love, S, et al.
Published: (1999)

Poly ADP-ribose polymerase-1: an international molecule of mystery.
by: Woodhouse, B, et al.
Published: (2008)

Structure and mechanism of a canonical poly(ADP-ribose) glycohydrolase.
by: Dunstan, MS, et al.
Published: (2012)

The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.
by: Slade, D, et al.
Published: (2011)

Family-wide analysis of poly(ADP-ribose) polymerase activity
by: Vyas, Sejal, et al.
Published: (2015)

The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in Gliomas
by: Nazanin Majd, et al.
Published: (2020-11-01)

Poly-ADP-ribose polymerase (PARP) inhibitors and ovarian function
by: Jiajia Li, et al.
Published: (2023-01-01)

Selective down-regulation of nuclear poly(ADP-ribose) glycohydrolase.
by: David M Burns, et al.
Published: (2009-01-01)

Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
by: Maurie Markman
Published: (2018-01-01)

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy
by: M. Javle, et al.
Published: (2011-11-01)

Crystallographic and biochemical analysis of the mouse poly(ADP-ribose) glycohydrolase.
by: Zhizhi Wang, et al.
Published: (2014-01-01)

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
by: Stephen A. Jannetti, et al.
Published: (2020-03-01)

Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
by: Chia-Hao Liu, et al.
Published: (2017-10-01)

Point‐of‐care Doppler ultrasound in the management of hyponatremia: Another string to nephrologists' Bow
by: Samira Samant, et al.
Published: (2021-08-01)

Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow
by: Jayant Kelwade, et al.
Published: (2014-01-01)

Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.
by: Gottipati, P, et al.
Published: (2010)

Identification of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases.
by: Chen, D, et al.
Published: (2011)